Ovarian Diseases  >>  Ovidrel (choriogonadotropin alfa)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ovidrel (choriogonadotropin alfa) / EMD Serono
NCT00989781: Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome

Completed
N/A
41
US
3-D Ultrasound, recombinant human chorionic gonadotropin, Ovidrel, r-hCG, Recombinant human follicle stimulating hormone, Gonal-F, r-hFSH, Adrenocorticotropin, Cosyntropin, ACTH, Dexamethasone, corticosteroid, Glucose, sugar
University of California, San Diego
Polycystic Ovary Syndrome
09/13
09/13
NCT01979341: The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes

Withdrawn
N/A
0
RoW
final oocyte maturation trigger, dual trigger: 6500 IU Ovitrelle (hCG) plus 0.2mg triptorelin acetate (GnRH agonist), hCG trigger: 6500 IU Ovitrelle (hCG), agonist trigger: 0.2mg triptorelin acetate (GnRH agonist)
Antalya IVF
Pregnancy, Ovarian Hyperstimulation Syndrome
06/16
09/16

Download Options